Unwanted Hormonal and Metabolic Effects of Postoperative Adjuvant Mitotane Treatment for Adrenocortical Cancer
出版年份 2020 全文链接
标题
Unwanted Hormonal and Metabolic Effects of Postoperative Adjuvant Mitotane Treatment for Adrenocortical Cancer
作者
关键词
-
出版物
Cancers
Volume 12, Issue 9, Pages 2615
出版商
MDPI AG
发表日期
2020-09-14
DOI
10.3390/cancers12092615
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Ovarian cyst formation in women of reproductive age receiving mitotane as part of the treatment of adrenocortical carcinoma: Clinical and experimental observations
- (2020) Gun Abrahamsson et al. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA
- New perspectives for mitotane treatment of adrenocortical carcinoma
- (2020) S. Puglisi et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Mitotane Concentrations Influence Outcome in Patients with Advanced Adrenocortical Carcinoma
- (2020) Soraya Puglisi et al. Cancers
- Harnessing the patient voice in real-world evidence: the essential role of patient-reported outcomes
- (2019) Melanie J. Calvert et al. NATURE REVIEWS DRUG DISCOVERY
- Adjuvant mitotane therapy is beneficial in non-metastatic adrenocortical carcinoma at high risk of recurrence
- (2019) A Calabrese et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
- (2019) François Mach et al. EUROPEAN HEART JOURNAL
- Mitotane Concentrations Influence the Risk of Recurrence in Adrenocortical Carcinoma Patients on Adjuvant Treatment
- (2019) Soraya Puglisi et al. Journal of Clinical Medicine
- Mitotane Monotherapy in Patients With Advanced Adrenocortical Carcinoma
- (2018) Felix Megerle et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors
- (2018) Martin Fassnacht et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Decision-making for adrenocortical carcinoma: surgical, systemic, and endocrine management options
- (2018) Soraya Puglisi et al. Expert Review of Anticancer Therapy
- Effects of mitotane on the hypothalamic–pituitary–adrenal axis in patients with adrenocortical carcinoma
- (2017) Giuseppe Reimondo et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Long-Term Outcomes of Adjuvant Mitotane Therapy in Patients With Radically Resected Adrenocortical Carcinoma
- (2017) Alfredo Berruti et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Mitotane treatment in patients with adrenocortical cancer causes central hypothyroidism
- (2015) Marco Russo et al. CLINICAL ENDOCRINOLOGY
- Mitotane Inhibits Sterol-O-Acyl Transferase 1 Triggering Lipid-Mediated Endoplasmic Reticulum Stress and Apoptosis in Adrenocortical Carcinoma Cells
- (2015) Silviu Sbiera et al. ENDOCRINOLOGY
- Lipid modification and cardiovascular risk assessment for the primary and secondary prevention of cardiovascular disease: summary of updated NICE guidance
- (2014) S. Rabar et al. BMJ-British Medical Journal
- Management of adrenal cancer: a 2013 update
- (2014) M. Terzolo et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Mitotane levels predict the outcome of patients with adrenocortical carcinoma treated adjuvantly following radical resection
- (2013) M Terzolo et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Mitotane-Induced Hyperlipidemia: A Retrospective Cohort Study
- (2013) Hassan Shawa et al. International Journal of Endocrinology
- Adrenal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2012) A. Berruti et al. ANNALS OF ONCOLOGY
- Mitotane Therapy in Adrenocortical Cancer Induces CYP3A4 and Inhibits 5α-Reductase, Explaining the Need for Personalized Glucocorticoid and Androgen Replacement
- (2012) Vasileios Chortis et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Drug interactions with mitotane by induction of CYP3A4 metabolism in the clinical management of adrenocortical carcinoma
- (2011) Matthias Kroiss et al. CLINICAL ENDOCRINOLOGY
- The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
- (2011) Walter L. Miller et al. ENDOCRINE REVIEWS
- Plasma Concentrations of o,p′DDD, o,p′DDA, and o,p′DDE as Predictors of Tumor Response to Mitotane in Adrenocortical Carcinoma: Results of a Retrospective ENS@T Multicenter Study
- (2011) Ilse G. Hermsen et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Sterol O-Acyltransferase 1 (SOAT1, ACAT) Is a Novel Target of Steroidogenic Factor-1 (SF-1, NR5A1, Ad4BP) in the Human Adrenal
- (2011) Bruno Ferraz-de-Souza et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Therapeutic Concentrations of Mitotane (o,p′-DDD) Inhibit Thyrotroph Cell Viability and TSH Expression and Secretion in a Mouse Cell Line Model
- (2010) Maria Chiara Zatelli et al. ENDOCRINOLOGY
- Improved Survival in Patients with Stage II Adrenocortical Carcinoma Followed Up Prospectively by Specialized Centers
- (2010) Martin Fassnacht et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The long-term survival in adrenocortical carcinoma with active surgical management and use of monitored mitotane
- (2009) B Wängberg et al. ENDOCRINE-RELATED CANCER
- Management of Endocrine Manifestations and the Use of Mitotane As a Chemotherapeutic Agent for Adrenocortical Carcinoma
- (2009) Irina Veytsman et al. JOURNAL OF CLINICAL ONCOLOGY
- Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma
- (2008) Martin Fassnacht et al. CANCER
- Prospective evaluation of mitotane toxicity in adrenocortical cancer patients treated adjuvantly
- (2008) F. Daffara et al. ENDOCRINE-RELATED CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now